REQUEST PRICE

Fields with * are required
Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

VPAC2 Receptor Antibodies

Close filters
No results were found for the filter!
NEW
pS425/pS429-VPAC2 (phospho-VIP Receptor 2 Antibody)
pS425/pS429-VPAC2 (phospho-VIP Receptor 2...
Serine425/Serine429 (S425/S429) is a major phosphorylation site of the VPAC2 receptor. The pS425/pS429-VPAC2 antibody detects phosphorylation in response to high-efficacy agonists. S425/S429 phosphorylation is a key regulator of VPAC2...
$ 350.00
NEW
Agonist-induced Serine411/Serine415 phosphorylation of VPAC2 Receptor
pS411/pS415-VPAC2 (phospho-VIP Receptor 2...
Serine411/Serine415 (S411/S415) is a major phosphorylation site of the VPAC2 receptor. The pS411/pS415-VPAC2 antibody detects phosphorylation in response to high-efficacy agonists. S411/S415 phosphorylation is a key regulator of VPAC2...
$ 350.00
NEW
Agonist-induced Serine408/Serine409 phosphorylation of VPAC2 Receptor
pS408/pS409-VPAC2 (phospho-VIP Receptor 2...
Serine408/Serine409 (S408/S409) is a major phosphorylation site of the VPAC2 receptor. The pS408/pS409-VPAC2 antibody detects phosphorylation in response to high-efficacy agonists. S408/S409 phosphorylation is a key regulator of VPAC2...
$ 350.00
Citations
KO-Validated
Validation of the VIP Receptor 2 in transfected HEK293 cells
VPAC2 (non-phospho), VIP Receptor 2 Antibody
The VPAC2 antibody is directed against the distal end of the carboxyl-terminal tail of mouse, rat and human VIP receptor 2. It can be used to detect total VPAC2 receptors in Western blots independent of phosphorylation. The VPAC2...
$ 350.00

The VPAC2 receptor, which responds to VIP and PACAP with comparable affinity. In the CNS, the highest concentrations of VPAC2 receptors are found in the thalamus and suprachiasmatic nucleus (SCN) and lower levels in the hippocampus, brainstem, spinal cord and dorsal root ganglia. The receptor is also present in many peripheral tissues, including smooth muscles in the cardiovascular, gastrointestinal and reproductive systems. A number of selective peptide agonists and an antagonist with some selectivity for the VPAC2 receptor have been reported. VPAC2 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine408/serine409 (pS408/pS409-VPAC2), serine411/serine415 (pS411/pS415-VPAC2) and serine425/serine429 (pS425/pS429-VPAC2). This nomenclature refers to the human VPAC2 receptor. This phosphorylation motif is conserved across species but corresponds to pS406/pS408-VPAC2, pS410/pS414-VPAC2 and pS424/pS428-VPAC2 in mice and rats. For more information on VPAC2 pharmacology please refer to the IUPHAR database. For further reading refer to:

Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012 May;166(1):4-17. doi: 10.1111/j.1476-5381.2012.01871.x. PMID: 22289055; PMCID: PMC3415633.

Laburthe M, Couvineau A, Marie JC. VPAC receptors for VIP and PACAP. Recept Channels. 2002;8(3-4):137-53. PMID: 12529932.

Fahrenkrug J, Goetzl EJ, Gozes I, Harmar A, Laburthe M, May V, Pisegna JR, Said SI, Vaudry H, Vaudry D, Waschek JA. VIP and PACAP receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(4).

The VPAC2 receptor, which responds to VIP and PACAP with comparable affinity. In the CNS, the highest concentrations of VPAC2 receptors are found in the thalamus and suprachiasmatic... read more »
Close window
VPAC2 Receptor Antibodies

The VPAC2 receptor, which responds to VIP and PACAP with comparable affinity. In the CNS, the highest concentrations of VPAC2 receptors are found in the thalamus and suprachiasmatic nucleus (SCN) and lower levels in the hippocampus, brainstem, spinal cord and dorsal root ganglia. The receptor is also present in many peripheral tissues, including smooth muscles in the cardiovascular, gastrointestinal and reproductive systems. A number of selective peptide agonists and an antagonist with some selectivity for the VPAC2 receptor have been reported. VPAC2 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine408/serine409 (pS408/pS409-VPAC2), serine411/serine415 (pS411/pS415-VPAC2) and serine425/serine429 (pS425/pS429-VPAC2). This nomenclature refers to the human VPAC2 receptor. This phosphorylation motif is conserved across species but corresponds to pS406/pS408-VPAC2, pS410/pS414-VPAC2 and pS424/pS428-VPAC2 in mice and rats. For more information on VPAC2 pharmacology please refer to the IUPHAR database. For further reading refer to:

Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012 May;166(1):4-17. doi: 10.1111/j.1476-5381.2012.01871.x. PMID: 22289055; PMCID: PMC3415633.

Laburthe M, Couvineau A, Marie JC. VPAC receptors for VIP and PACAP. Recept Channels. 2002;8(3-4):137-53. PMID: 12529932.

Fahrenkrug J, Goetzl EJ, Gozes I, Harmar A, Laburthe M, May V, Pisegna JR, Said SI, Vaudry H, Vaudry D, Waschek JA. VIP and PACAP receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(4).

Recently viewed